Unknown

Dataset Information

0

Heart rate and early progression of cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis.


ABSTRACT:

Introduction

Heart rate slowing agents are frequently prescribed to manage heart transplant (HTx) patients with the assumption that higher heart rate is a risk factor in cardiovascular disease.

Patients and methods

This prospective two-center study investigated early progression of cardiac allograft vasculopathy (CAV) in 116 HTx patients. Examinations by coronary optical coherence tomography and 24-hour ambulatory ECG monitoring were performed both at baseline (1 month after HTx) and during follow-up (12 months after HTx).

Results

During the first post-HTx year, we observed a significant reduction in the mean coronary luminal area from 9.0 ± 2.5 to 8.0 ± 2.4 mm2 (P < .001), and progression in mean intimal thickness (IT) from 106.5 ± 40.4 to 130.1 ± 53.0 µm (P < .001). No significant relationship was observed between baseline and follow-up mean heart rates and IT progression (R = .02, P = .83; R = -.13, P = .18). We found a mild inverse association between beta-blocker dosage at 12 months and IT progression (R = -.20, P = .035).

Conclusion

Our study did not confirm a direct association between mean heart rate and progression of CAV. The role of beta blockers warrants further investigation, with our results indicating that they may play a protective role in early CAV development.

SUBMITTER: Pazdernik M 

PROVIDER: S-EPMC7220813 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Heart rate and early progression of cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis.

Pazdernik Michal M   Wichterle Dan D   Chen Zhi Z   Bedanova Helena H   Kautzner Josef J   Melenovsky Vojtech V   Karmazin Vladimir V   Malek Ivan I   Stiavnicky Peter P   Tomasek Ales A   Ozabalova Eva E   Krejci Jan J   Wahle Andreas A   Zhang Honghai H   Kovarnik Tomas T   Sonka Milan M  

Clinical transplantation 20200109 2


<h4>Introduction</h4>Heart rate slowing agents are frequently prescribed to manage heart transplant (HTx) patients with the assumption that higher heart rate is a risk factor in cardiovascular disease.<h4>Patients and methods</h4>This prospective two-center study investigated early progression of cardiac allograft vasculopathy (CAV) in 116 HTx patients. Examinations by coronary optical coherence tomography and 24-hour ambulatory ECG monitoring were performed both at baseline (1 month after HTx)  ...[more]

Similar Datasets

| S-EPMC8710340 | biostudies-literature
| S-EPMC10481782 | biostudies-literature
| S-EPMC5324107 | biostudies-literature
| S-EPMC6327279 | biostudies-literature
| S-EPMC6753124 | biostudies-literature
| S-EPMC10866736 | biostudies-literature
| S-EPMC6018370 | biostudies-literature
| S-EPMC6697318 | biostudies-literature
| S-EPMC6110499 | biostudies-literature
| S-EPMC6583551 | biostudies-literature